| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADP+ binding | 1.11e-06 | 9 | 197 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.76e-06 | 4 | 197 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.76e-06 | 4 | 197 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.76e-06 | 4 | 197 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 8.51e-06 | 14 | 197 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.51e-06 | 14 | 197 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 9.32e-06 | 5 | 197 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 9.32e-06 | 5 | 197 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 9.32e-06 | 5 | 197 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 9.32e-06 | 5 | 197 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 9.32e-06 | 5 | 197 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 9.32e-06 | 5 | 197 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 9.32e-06 | 5 | 197 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.85e-05 | 6 | 197 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 3.22e-05 | 7 | 197 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 5.11e-05 | 8 | 197 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 5.11e-05 | 8 | 197 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 5.11e-05 | 8 | 197 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 7.60e-05 | 9 | 197 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | prostaglandin H2 endoperoxidase reductase activity | 9.68e-05 | 2 | 197 | 2 | GO:0036130 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.08e-04 | 10 | 197 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.08e-04 | 10 | 197 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.35e-04 | 27 | 197 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 1.47e-04 | 11 | 197 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.66e-04 | 32 | 197 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 3.38e-04 | 34 | 197 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid binding | 3.57e-04 | 133 | 197 | 7 | GO:0005496 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 5.74e-04 | 4 | 197 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 6.36e-04 | 40 | 197 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 9.53e-04 | 20 | 197 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.27e-03 | 48 | 197 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.64e-03 | 24 | 197 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.97e-03 | 7 | 197 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.97e-03 | 7 | 197 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 2.08e-03 | 26 | 197 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.08e-03 | 26 | 197 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.08e-03 | 26 | 197 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.26e-03 | 56 | 197 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.91e-03 | 60 | 197 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.16e-03 | 30 | 197 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.28e-03 | 62 | 197 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.28e-03 | 62 | 197 | 4 | GO:0050661 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.00e-06 | 9 | 198 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.65e-06 | 10 | 198 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.65e-06 | 10 | 198 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.65e-06 | 10 | 198 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.46e-06 | 4 | 198 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.46e-06 | 4 | 198 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.46e-06 | 4 | 198 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.46e-06 | 4 | 198 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 8.59e-06 | 5 | 198 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 8.59e-06 | 5 | 198 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 8.59e-06 | 5 | 198 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 8.59e-06 | 5 | 198 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 8.59e-06 | 5 | 198 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 8.59e-06 | 5 | 198 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.71e-05 | 6 | 198 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.71e-05 | 6 | 198 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.96e-05 | 7 | 198 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.96e-05 | 7 | 198 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.96e-05 | 7 | 198 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.34e-05 | 21 | 198 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 5.26e-05 | 22 | 198 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 5.26e-05 | 22 | 198 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 9.95e-05 | 10 | 198 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 9.95e-05 | 10 | 198 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.36e-04 | 11 | 198 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.36e-04 | 11 | 198 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.99e-04 | 56 | 198 | 5 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 2.16e-04 | 57 | 198 | 5 | GO:0006692 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.93e-04 | 14 | 198 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.93e-04 | 14 | 198 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.05e-04 | 34 | 198 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.64e-04 | 15 | 198 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 4.45e-04 | 16 | 198 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 4.45e-04 | 16 | 198 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 4.51e-04 | 142 | 198 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.62e-04 | 67 | 198 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.74e-04 | 40 | 198 | 4 | GO:0042573 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 6.84e-05 | 9 | 199 | 3 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 6.84e-05 | 9 | 199 | 3 | GO:0005943 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.45e-06 | 10 | 198 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.45e-06 | 10 | 198 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.45e-06 | 10 | 198 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 2.45e-06 | 10 | 198 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.45e-06 | 10 | 198 | 4 | IPR020471 | |
| Domain | ARM-type_fold | USP34 SMG1 VPS11 NOC2L UNC45A ARMC2 PLAA PIK3CD PIK3CG INTS7 UBR4 RTTN WDFY4 RANBP17 ARID2 | 3.51e-06 | 339 | 198 | 15 | IPR016024 |
| Domain | TPR-like_helical_dom | TANC2 VPS11 RGPD1 TMTC2 UNC45A CDC16 NRDE2 CAPN7 CSTF3 SEL1L2 LONRF3 CDC27 | 7.50e-06 | 233 | 198 | 12 | IPR011990 |
| Domain | - | 2.02e-05 | 16 | 198 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 2.62e-05 | 17 | 198 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 2.62e-05 | 17 | 198 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.62e-05 | 17 | 198 | 4 | IPR001395 | |
| Domain | - | TANC2 VPS11 RGPD1 TMTC2 UNC45A CDC16 NRDE2 CSTF3 SEL1L2 LONRF3 | 7.49e-05 | 207 | 198 | 10 | 1.25.40.10 |
| Domain | ZINC_FINGER_C2H2_2 | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF702P ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ARID2 ZNF816 ZNF69 ZNF639 ZNF292 | 7.91e-05 | 775 | 198 | 21 | PS50157 |
| Domain | WD40_repeat_dom | VPS11 NOL10 NEDD1 PLAA NWD1 WDR36 UBR4 NOL11 WDFY4 WDHD1 WDR12 EIF2A | 8.16e-05 | 297 | 198 | 12 | IPR017986 |
| Domain | ZINC_FINGER_C2H2_1 | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF702P ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ARID2 ZNF816 ZNF69 ZNF639 ZNF292 | 8.20e-05 | 777 | 198 | 21 | PS00028 |
| Domain | Znf_C2H2 | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF702P ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ARID2 ZNF816 ZNF69 ZNF639 ZNF292 | 1.34e-04 | 805 | 198 | 21 | IPR007087 |
| Domain | ZnF_C2H2 | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF702P ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ARID2 ZNF816 ZNF69 ZNF639 ZNF292 | 1.41e-04 | 808 | 198 | 21 | SM00355 |
| Domain | zf-C2H2 | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF702P ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 ZNF639 ZNF292 | 1.51e-04 | 693 | 198 | 19 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 ZNF639 ZNF292 | 1.54e-04 | 694 | 198 | 19 | IPR013087 |
| Domain | - | VPS11 NOL10 NEDD1 PLXNB2 PLAA NWD1 WDR36 NOL11 WDFY4 WDHD1 WDR12 EIF2A | 2.37e-04 | 333 | 198 | 12 | 2.130.10.10 |
| Domain | Oxysterol-bd_CS | 2.41e-04 | 12 | 198 | 3 | IPR018494 | |
| Domain | Oxysterol_BP | 2.41e-04 | 12 | 198 | 3 | PF01237 | |
| Domain | Oxysterol-bd | 2.41e-04 | 12 | 198 | 3 | IPR000648 | |
| Domain | OSBP | 2.41e-04 | 12 | 198 | 3 | PS01013 | |
| Domain | WD40/YVTN_repeat-like_dom | VPS11 NOL10 NEDD1 PLXNB2 PLAA NWD1 WDR36 NOL11 WDFY4 WDHD1 WDR12 EIF2A | 2.50e-04 | 335 | 198 | 12 | IPR015943 |
| Domain | Znf_C2H2-like | HIVEP1 VEZF1 ZNF268 ZNF177 ZNF831 ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ARID2 ZNF816 ZNF69 ZNF639 ZNF292 | 3.18e-04 | 796 | 198 | 20 | IPR015880 |
| Domain | - | HIVEP1 VEZF1 ZNF268 ZNF831 ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 ZNF639 ZNF292 | 3.40e-04 | 679 | 198 | 18 | 3.30.160.60 |
| Domain | TPR | 4.55e-04 | 129 | 198 | 7 | SM00028 | |
| Domain | PI3/4_kinase_CS | 4.86e-04 | 15 | 198 | 3 | IPR018936 | |
| Domain | zf-C2H2_6 | ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 | 5.45e-04 | 314 | 198 | 11 | PF13912 |
| Domain | TPR_repeat | 5.46e-04 | 133 | 198 | 7 | IPR019734 | |
| Domain | - | 5.94e-04 | 16 | 198 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.94e-04 | 16 | 198 | 3 | SM00146 | |
| Domain | PH_dom-like | ARHGAP42 TBC1D2B RGPD1 ARHGEF16 ANLN OSBPL9 OSBPL8 OSBPL11 PHLPP1 FRMPD2 WDFY4 TNS4 PHLPP2 | 6.43e-04 | 426 | 198 | 13 | IPR011993 |
| Domain | PI3K_ABD | 6.62e-04 | 4 | 198 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 6.62e-04 | 4 | 198 | 2 | IPR003113 | |
| Domain | WD_REPEATS_1 | 7.92e-04 | 278 | 198 | 10 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.15e-04 | 279 | 198 | 10 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.15e-04 | 279 | 198 | 10 | PS50294 | |
| Domain | PI3_PI4_kinase | 8.51e-04 | 18 | 198 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 8.51e-04 | 18 | 198 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.51e-04 | 18 | 198 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 8.51e-04 | 18 | 198 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 8.51e-04 | 18 | 198 | 3 | PS50290 | |
| Domain | - | ARHGAP42 TBC1D2B RGPD1 ARHGEF16 ANLN OSBPL9 OSBPL8 OSBPL11 PHLPP1 FRMPD2 TNS4 PHLPP2 | 9.85e-04 | 391 | 198 | 12 | 2.30.29.30 |
| Domain | DUF3504 | 1.09e-03 | 5 | 198 | 2 | IPR021893 | |
| Domain | TIF_beta_prop-like | 1.09e-03 | 5 | 198 | 2 | IPR013979 | |
| Domain | eIF2A | 1.09e-03 | 5 | 198 | 2 | PF08662 | |
| Domain | DUF3504 | 1.09e-03 | 5 | 198 | 2 | PF12012 | |
| Domain | TPR-contain_dom | 1.11e-03 | 150 | 198 | 7 | IPR013026 | |
| Domain | Apc4_WD40_dom | 1.17e-03 | 20 | 198 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.17e-03 | 20 | 198 | 3 | PF12894 | |
| Domain | KRAB | ZNF268 ZNF177 ZNF440 ZNF836 ZNF433 ZNF211 ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 | 1.58e-03 | 358 | 198 | 11 | PS50805 |
| Domain | KRAB | ZNF268 ZNF177 ZNF440 ZNF836 ZNF433 ZNF211 ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 | 1.58e-03 | 358 | 198 | 11 | PF01352 |
| Domain | NACHT | 1.78e-03 | 23 | 198 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 1.78e-03 | 23 | 198 | 3 | IPR007111 | |
| Domain | TPR_REGION | 1.92e-03 | 165 | 198 | 7 | PS50293 | |
| Domain | TPR | 1.92e-03 | 165 | 198 | 7 | PS50005 | |
| Domain | KRAB | ZNF268 ZNF177 ZNF440 ZNF836 ZNF433 ZNF211 ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 | 2.00e-03 | 369 | 198 | 11 | SM00349 |
| Domain | KRAB | ZNF268 ZNF177 ZNF440 ZNF836 ZNF433 ZNF211 ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 | 2.04e-03 | 370 | 198 | 11 | IPR001909 |
| Domain | PI3K_Ras-bd_dom | 2.27e-03 | 7 | 198 | 2 | IPR000341 | |
| Domain | Znf_MYM | 2.27e-03 | 7 | 198 | 2 | IPR010507 | |
| Domain | PI3K_rbd | 2.27e-03 | 7 | 198 | 2 | SM00144 | |
| Domain | PI3K_rbd | 2.27e-03 | 7 | 198 | 2 | PF00794 | |
| Domain | PI3K_RBD | 2.27e-03 | 7 | 198 | 2 | PS51546 | |
| Domain | zf-FCS | 2.27e-03 | 7 | 198 | 2 | PF06467 | |
| Domain | TPR_8 | 2.39e-03 | 53 | 198 | 4 | PF13181 | |
| Domain | ARM-like | 2.42e-03 | 270 | 198 | 9 | IPR011989 | |
| Domain | WD40_repeat | 2.54e-03 | 272 | 198 | 9 | IPR001680 | |
| Domain | TPR_1 | 2.70e-03 | 90 | 198 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.70e-03 | 90 | 198 | 5 | PF00515 | |
| Domain | LRR_6 | 2.74e-03 | 55 | 198 | 4 | PF13516 | |
| Domain | TRASH_dom | 3.00e-03 | 8 | 198 | 2 | IPR011017 | |
| Domain | TRASH | 3.00e-03 | 8 | 198 | 2 | SM00746 | |
| Domain | PI3K_C2 | 3.00e-03 | 8 | 198 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 3.00e-03 | 8 | 198 | 2 | IPR002420 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 3.00e-03 | 8 | 198 | 2 | IPR009011 | |
| Domain | PI3K_C2 | 3.00e-03 | 8 | 198 | 2 | PF00792 | |
| Domain | PI3K_C2 | 3.00e-03 | 8 | 198 | 2 | PS51547 | |
| Domain | PH_DOMAIN | ARHGAP42 TBC1D2B ARHGEF16 ANLN OSBPL9 OSBPL8 OSBPL11 PHLPP1 PHLPP2 | 3.01e-03 | 279 | 198 | 9 | PS50003 |
| Domain | PH | 3.14e-03 | 229 | 198 | 8 | PF00169 | |
| Domain | PI3Ka | 3.83e-03 | 9 | 198 | 2 | PF00613 | |
| Domain | PI3Ka | 3.83e-03 | 9 | 198 | 2 | SM00145 | |
| Domain | - | 3.83e-03 | 9 | 198 | 2 | 1.25.40.70 | |
| Domain | SH2 | 4.43e-03 | 101 | 198 | 5 | PF00017 | |
| Domain | CNMP_BINDING_1 | 4.64e-03 | 32 | 198 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 4.64e-03 | 32 | 198 | 3 | PS00889 | |
| Domain | PI_Kinase | 4.76e-03 | 10 | 198 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 4.76e-03 | 10 | 198 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 4.76e-03 | 10 | 198 | 2 | PS51545 | |
| Domain | cNMP | 5.51e-03 | 34 | 198 | 3 | SM00100 | |
| Domain | cNMP_binding | 5.51e-03 | 34 | 198 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 5.98e-03 | 35 | 198 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 5.98e-03 | 35 | 198 | 3 | PS50042 | |
| Domain | SH2 | 6.35e-03 | 110 | 198 | 5 | SM00252 | |
| Domain | SH2 | 6.59e-03 | 111 | 198 | 5 | PS50001 | |
| Domain | SH2 | 6.84e-03 | 112 | 198 | 5 | IPR000980 | |
| Domain | - | 6.84e-03 | 112 | 198 | 5 | 3.30.505.10 | |
| Domain | FAD-dep_OxRdtase | 6.88e-03 | 12 | 198 | 2 | IPR006076 | |
| Domain | DAO | 6.88e-03 | 12 | 198 | 2 | PF01266 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 6.18e-05 | 9 | 130 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 6.18e-05 | 9 | 130 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.20e-04 | 11 | 130 | 3 | M47812 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.59e-04 | 12 | 130 | 3 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.59e-04 | 12 | 130 | 3 | MM15623 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.05e-04 | 13 | 130 | 3 | MM14747 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.05e-04 | 13 | 130 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.30e-04 | 33 | 130 | 4 | MM14737 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.30e-04 | 33 | 130 | 4 | M5967 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 2.59e-04 | 14 | 130 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.59e-04 | 14 | 130 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 2.59e-04 | 14 | 130 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.59e-04 | 14 | 130 | 3 | MM14748 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.59e-04 | 14 | 130 | 3 | M16884 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.59e-04 | 14 | 130 | 3 | MM1485 | |
| Pathway | WP_FERROPTOSIS | 3.04e-04 | 64 | 130 | 5 | M39768 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 3.22e-04 | 15 | 130 | 3 | MM14870 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 3.22e-04 | 15 | 130 | 3 | M47971 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC | 4.74e-04 | 17 | 130 | 3 | M47888 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 4.74e-04 | 17 | 130 | 3 | MM15584 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 4.88e-04 | 40 | 130 | 4 | M39695 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.18e-04 | 113 | 130 | 6 | MM14783 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 7.04e-04 | 44 | 130 | 4 | M499 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 7.68e-04 | 45 | 130 | 4 | M39355 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 7.68e-04 | 45 | 130 | 4 | MM14751 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 7.77e-04 | 118 | 130 | 6 | M713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 7.79e-04 | 20 | 130 | 3 | M16355 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 8.29e-04 | 5 | 130 | 2 | M48997 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 8.35e-04 | 46 | 130 | 4 | MM15837 | |
| Pathway | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | 9.03e-04 | 21 | 130 | 3 | M489 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 9.03e-04 | 21 | 130 | 3 | M8601 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 9.03e-04 | 21 | 130 | 3 | MM15633 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 9.03e-04 | 21 | 130 | 3 | M47583 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 9.03e-04 | 21 | 130 | 3 | MM1463 | |
| Pathway | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | 9.03e-04 | 21 | 130 | 3 | MM14560 | |
| Pathway | PID_PI3KCI_PATHWAY | 9.82e-04 | 48 | 130 | 4 | M141 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.04e-03 | 22 | 130 | 3 | M903 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.09e-03 | 126 | 130 | 6 | MM15553 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 1.12e-03 | 85 | 130 | 5 | M3578 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.19e-03 | 23 | 130 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.19e-03 | 23 | 130 | 3 | MM14741 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.19e-03 | 23 | 130 | 3 | M1926 | |
| Pathway | REACTOME_GDP_FUCOSE_BIOSYNTHESIS | 1.24e-03 | 6 | 130 | 2 | MM15322 | |
| Pathway | REACTOME_GDP_FUCOSE_BIOSYNTHESIS | 1.24e-03 | 6 | 130 | 2 | M27611 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.25e-03 | 87 | 130 | 5 | MM15915 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 1.33e-03 | 52 | 130 | 4 | M7561 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 1.35e-03 | 24 | 130 | 3 | MM1467 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.52e-03 | 25 | 130 | 3 | M27865 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 1.52e-03 | 25 | 130 | 3 | M85 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.52e-03 | 25 | 130 | 3 | MM1465 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.60e-03 | 92 | 130 | 5 | MM14881 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.64e-03 | 55 | 130 | 4 | M14933 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.68e-03 | 137 | 130 | 6 | M18155 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 1.71e-03 | 26 | 130 | 3 | MM14697 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 1.71e-03 | 26 | 130 | 3 | M1079 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K | 1.72e-03 | 7 | 130 | 2 | M27910 | |
| Pubmed | USP34 MAP4 STXBP4 ANKHD1 AKR1C1 AKR1C2 PLAA ANLN PIK3CD PIK3R1 OSBPL11 DNA2 FAM135A COG4 NRDE2 ANK3 TMEM254 NOL11 INO80 WDFY4 SLC7A1 IGF2R WDHD1 TIMP3 GRAMD2B AKR1C3 CDC27 | 3.51e-10 | 1084 | 206 | 27 | 11544199 | |
| Pubmed | 1.78e-08 | 6 | 206 | 4 | 19273550 | ||
| Pubmed | 8.21e-08 | 8 | 206 | 4 | 20837989 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 2.05e-07 | 3 | 206 | 3 | 31780644 | |
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 13678667 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 34663797 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 21232532 | ||
| Pubmed | ATP6AP1 NOC2L STXBP4 UNC45A RRM1 PLXNB2 PIK3R1 BUB1B OSBPL8 PDZD8 GMDS HERC2 DNA2 FAM135A WDR36 ANK3 UBR4 NOL11 SPG11 LGALS3BP AIFM2 IARS2 IGF2R DPP9 STEAP3 WDR12 EIF2A | 2.50e-07 | 1487 | 206 | 27 | 33957083 | |
| Pubmed | ATP6AP1 GTPBP6 VEZF1 MAP4 NOC2L ZMYM2 GON4L NOL10 UNC45A ANKHD1 BBX ANLN CDC16 OSBPL8 HERC2 NRDE2 WDR36 INTS7 NOL11 INO80 SRBD1 ARID2 CSTF3 WDR12 EIF2A CDC27 ZMYM3 | 2.85e-07 | 1497 | 206 | 27 | 31527615 | |
| Pubmed | 5.70e-07 | 12 | 206 | 4 | 12551992 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 8.16e-07 | 4 | 206 | 3 | 10500239 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 8.16e-07 | 4 | 206 | 3 | 14967952 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 8.16e-07 | 4 | 206 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 8.16e-07 | 4 | 206 | 3 | 31479646 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 18006698 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 16191478 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 15577209 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 10702227 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 8.16e-07 | 4 | 206 | 3 | 29764944 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 17888864 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 17442338 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 28329705 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 19237748 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 28259989 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 16511129 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 7789999 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 8.16e-07 | 4 | 206 | 3 | 16508162 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 15222881 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 17629694 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 10526179 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 16018803 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 8.16e-07 | 4 | 206 | 3 | 18667791 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 21521174 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 8274401 | ||
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 8.16e-07 | 4 | 206 | 3 | 34590152 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRIP1 SPEG TBC1D2B OSBPL8 NWD1 ZNF211 ANK3 SPG11 VPS13D CAPN7 ARID2 WDR12 CTPS1 ZNF292 | 1.84e-06 | 497 | 206 | 14 | 36774506 |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.03e-06 | 5 | 206 | 3 | 21851338 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 20200404 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 10477750 | ||
| Pubmed | Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. | 2.03e-06 | 5 | 206 | 3 | 12774123 | |
| Pubmed | Rapid microtubule-independent dynamics of Cdc20 at kinetochores and centrosomes in mammalian cells. | 2.03e-06 | 5 | 206 | 3 | 12196507 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.03e-06 | 5 | 206 | 3 | 16984997 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 7737980 | ||
| Pubmed | Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. | 2.03e-06 | 5 | 206 | 3 | 20038597 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.03e-06 | 5 | 206 | 3 | 17064890 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 10672042 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 38788959 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 18003893 | ||
| Pubmed | USP34 MAP4 NOC2L ACLY NOL10 ANKHD1 OSBPL8 HERC2 CAP1 WDR36 UBR4 NOL11 IARS2 IGF2R WDR12 ZMYM3 | 2.04e-06 | 653 | 206 | 16 | 22586326 | |
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 2.06e-06 | 16 | 206 | 4 | 16524887 | |
| Pubmed | DENND4A ATP6AP1 PIK3R1 OSBPL9 OSBPL8 OSBPL11 PDZD8 FAM135A COG4 GPD2 SPG11 VPS13D IGF2R STEAP3 | 2.16e-06 | 504 | 206 | 14 | 34432599 | |
| Pubmed | 2.48e-06 | 101 | 206 | 7 | 10997877 | ||
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 2.68e-06 | 17 | 206 | 4 | 12960231 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 VEZF1 ZMYM2 FSIP2 BBX ANLN HERC2 INO80 SRBD1 RLF ARID2 WDR12 CDC27 ZMYM3 ZNF292 | 3.96e-06 | 608 | 206 | 15 | 36089195 |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.04e-06 | 6 | 206 | 3 | 26748576 | |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 21335556 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.04e-06 | 6 | 206 | 3 | 29107092 | |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 15860270 | ||
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.04e-06 | 6 | 206 | 3 | 17255200 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 4.32e-06 | 19 | 206 | 4 | 17599069 | |
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 20167705 | ||
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 22529366 | ||
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 33127481 | ||
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 12562828 | ||
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 7.04e-06 | 7 | 206 | 3 | 34843575 | |
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 19846565 | ||
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 16337335 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 7.82e-06 | 168 | 206 | 8 | 30631154 | |
| Pubmed | USP34 NRIP1 HIVEP1 RGPD1 ZMYM2 UNC45A ANKHD1 BUB1B NAV1 UBR4 RLF ZMYM3 | 8.41e-06 | 418 | 206 | 12 | 34709266 | |
| Pubmed | 1.12e-05 | 8 | 206 | 3 | 33584538 | ||
| Pubmed | 1.12e-05 | 8 | 206 | 3 | 9224647 | ||
| Pubmed | 1.37e-05 | 25 | 206 | 4 | 26098214 | ||
| Pubmed | 1.68e-05 | 9 | 206 | 3 | 33348080 | ||
| Pubmed | 1.68e-05 | 9 | 206 | 3 | 21765914 | ||
| Pubmed | ATP6AP1 NOC2L STXBP4 NOL10 RRM1 CDC16 BUB1B DNA2 WDR36 SLC7A1 CSTF3 CDC27 | 1.79e-05 | 451 | 206 | 12 | 30033366 | |
| Pubmed | 1.89e-05 | 27 | 206 | 4 | 17077188 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 1.89e-05 | 27 | 206 | 4 | 14581517 | |
| Pubmed | MAP4 ACLY UNC45A RRM1 BUB1B OSBPL8 PDZD8 FAM135A CAP1 GPD2 ANK3 IGF2R CTPS1 EIF2A CDC27 | 2.38e-05 | 708 | 206 | 15 | 39231216 | |
| Pubmed | 2.38e-05 | 10 | 206 | 3 | 9113989 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 2.38e-05 | 10 | 206 | 3 | 36313771 | |
| Pubmed | 2.38e-05 | 10 | 206 | 3 | 8798481 | ||
| Pubmed | The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. | 2.38e-05 | 10 | 206 | 3 | 18997788 | |
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 2.38e-05 | 10 | 206 | 3 | 9247029 | |
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 2.38e-05 | 10 | 206 | 3 | 8636073 | |
| Pubmed | Stable MCC binding to the APC/C is required for a functional spindle assembly checkpoint. | 2.38e-05 | 10 | 206 | 3 | 24464857 | |
| Pubmed | 2.38e-05 | 10 | 206 | 3 | 25673878 | ||
| Pubmed | NOL10 RRM1 ANLN BUB1B OSBPL9 OSBPL8 WDR36 SRBD1 IGF2R ARID2 CSTF3 STEAP3 | 2.79e-05 | 472 | 206 | 12 | 38943005 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 3.12e-05 | 331 | 206 | 10 | 19490893 | |
| Cytoband | 10p15-p14 | 1.76e-06 | 6 | 206 | 3 | 10p15-p14 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF717 HIVEP1 VEZF1 ZNF268 ZNF177 ZNF440 ZNF836 ZNF117 ZNF433 ZFP62 ZNF211 RLF ZNF26 ZNF425 ZNF728 ZNF816 ZNF69 ZNF639 ZNF292 | 3.91e-06 | 718 | 143 | 19 | 28 |
| GeneFamily | Aldo-keto reductases | 4.79e-06 | 15 | 143 | 4 | 399 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.01e-04 | 12 | 143 | 3 | 670 | |
| GeneFamily | Zinc fingers MYM-type | 9.13e-04 | 6 | 143 | 2 | 86 | |
| GeneFamily | NLR family | 9.81e-04 | 25 | 143 | 3 | 666 | |
| GeneFamily | SH2 domain containing | 1.24e-03 | 101 | 143 | 5 | 741 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.27e-03 | 206 | 143 | 7 | 682 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.69e-03 | 8 | 143 | 2 | 831 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.21e-03 | 115 | 143 | 5 | 769 | |
| GeneFamily | WD repeat domain containing | 4.88e-03 | 262 | 143 | 7 | 362 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 5.31e-03 | 14 | 143 | 2 | 402 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 7.68e-06 | 17 | 203 | 4 | MM826 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 NRIP1 HIVEP1 VEZF1 ZMYM2 BBX CDC16 BUB1B NAV3 OSBPL8 PHLPP1 SPG11 ADGRG6 RLF SLC7A1 IGF2R WDHD1 CDC27 PHLPP2 ZNF292 | 1.22e-05 | 856 | 203 | 20 | M4500 |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 2.66e-05 | 199 | 203 | 9 | M6450 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 2.76e-05 | 200 | 203 | 9 | M9657 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_UP | 2.76e-05 | 200 | 203 | 9 | M5461 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TANC2 ZNF717 SMG1 DENND4A MCMDC2 FBXL5 PHKA1 PLAA ANLN GMDS DNA2 KIT FAM135A WDR36 SRBD1 CINP USP26 RANBP17 M1AP IARS2 WDHD1 CTPS1 | 8.90e-06 | 820 | 198 | 22 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | TANC2 NRIP1 AKR1C1 AKR1C2 OSBPL11 AKR1B1 GPD2 SLC7A7 LGALS3BP AKR1C3 | 1.64e-08 | 185 | 206 | 10 | 85cb81759589a26d83676cffbf2bc37399683c10 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 SMG1 PIK3R1 ANK3 TRIM73 RTTN ABCA5 ANKRD36 MCTP2 ZNF292 | 3.27e-08 | 199 | 206 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-08 | 70 | 206 | 7 | 37e34ef782b253c43628d5bb2fe5e0294573d0ef | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-07 | 178 | 206 | 9 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-07 | 197 | 206 | 9 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.77e-07 | 198 | 206 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.77e-07 | 198 | 206 | 9 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.77e-07 | 198 | 206 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.77e-07 | 198 | 206 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 165 | 206 | 8 | 2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.14e-06 | 167 | 206 | 8 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-06 | 168 | 206 | 8 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-06 | 169 | 206 | 8 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-06 | 185 | 206 | 8 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.46e-06 | 185 | 206 | 8 | 5ec2c3ae5c477645241e8eaf19d222562e1f7ed6 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 3.00e-06 | 190 | 206 | 8 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 193 | 206 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-06 | 195 | 206 | 8 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-06 | 196 | 206 | 8 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 3.78e-06 | 196 | 206 | 8 | f73573b5d9c735f2a2c718472b7d12b10f2a3718 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-06 | 197 | 206 | 8 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.92e-06 | 197 | 206 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-06 | 198 | 206 | 8 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-06 | 198 | 206 | 8 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 140 | 206 | 7 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-06 | 199 | 206 | 8 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.22e-06 | 199 | 206 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 199 | 206 | 8 | 54167894a16e975d0541cbe3e515bcfa183044f6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-06 | 152 | 206 | 7 | c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-06 | 152 | 206 | 7 | c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-06 | 152 | 206 | 7 | cefc0ab592e99badf145fb95adf9906cb81be81c | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.34e-06 | 153 | 206 | 7 | e9567966fe4426176e2f2dc0be4832c769c9903a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-06 | 102 | 206 | 6 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-06 | 102 | 206 | 6 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-06 | 102 | 206 | 6 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-06 | 102 | 206 | 6 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.00e-06 | 102 | 206 | 6 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.43e-06 | 159 | 206 | 7 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 167 | 206 | 7 | b85fd7ab21c80470bca804c788ce49a2bce763f8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 169 | 206 | 7 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 169 | 206 | 7 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.40e-05 | 169 | 206 | 7 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 171 | 206 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 173 | 206 | 7 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.63e-05 | 173 | 206 | 7 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.63e-05 | 173 | 206 | 7 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | Control-Lymphoid-ILC_B|World / Disease state, Lineage and Cell class | 1.82e-05 | 176 | 206 | 7 | 57ad9c9f5fda6bc24695587ed14190514fd8d96a | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.82e-05 | 176 | 206 | 7 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 177 | 206 | 7 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 178 | 206 | 7 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 178 | 206 | 7 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.96e-05 | 178 | 206 | 7 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 178 | 206 | 7 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 179 | 206 | 7 | 330c1326ba93bb8f32559ee1cc40e357cc44ad8d | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 179 | 206 | 7 | dc03b9045510eb1bb934329646bb92dd06890ce9 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 180 | 206 | 7 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 2.11e-05 | 180 | 206 | 7 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 2.11e-05 | 180 | 206 | 7 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 181 | 206 | 7 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 2.18e-05 | 181 | 206 | 7 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.18e-05 | 181 | 206 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 183 | 206 | 7 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 183 | 206 | 7 | ffa7f2b2929ea4bd53f3f1ae23bd27f8bb4aac47 | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 2.34e-05 | 183 | 206 | 7 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.34e-05 | 183 | 206 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 183 | 206 | 7 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.43e-05 | 184 | 206 | 7 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-05 | 184 | 206 | 7 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-05 | 184 | 206 | 7 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 184 | 206 | 7 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.43e-05 | 184 | 206 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.60e-05 | 186 | 206 | 7 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-05 | 186 | 206 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.60e-05 | 186 | 206 | 7 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.60e-05 | 186 | 206 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.60e-05 | 186 | 206 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.69e-05 | 187 | 206 | 7 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 187 | 206 | 7 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.69e-05 | 187 | 206 | 7 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-05 | 188 | 206 | 7 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-05 | 188 | 206 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 188 | 206 | 7 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.78e-05 | 188 | 206 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 189 | 206 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 189 | 206 | 7 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.88e-05 | 189 | 206 | 7 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 189 | 206 | 7 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-05 | 190 | 206 | 7 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-05 | 190 | 206 | 7 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 190 | 206 | 7 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 190 | 206 | 7 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.98e-05 | 190 | 206 | 7 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 190 | 206 | 7 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 190 | 206 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.98e-05 | 190 | 206 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 206 | 7 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 191 | 206 | 7 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 206 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 192 | 206 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.18e-05 | 192 | 206 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| Drug | 4-hydroxyequilenin-o-quinone | 2.06e-07 | 7 | 202 | 4 | ctd:C117714 | |
| Drug | cyclopentanol | 6.88e-07 | 3 | 202 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 6.88e-07 | 3 | 202 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 6.88e-07 | 3 | 202 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 6.88e-07 | 3 | 202 | 3 | ctd:C530610 | |
| Drug | benzene dihydrodiol | 1.22e-06 | 22 | 202 | 5 | CID000000418 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.89e-06 | 11 | 202 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.89e-06 | 11 | 202 | 4 | CID000013946 | |
| Drug | cloxazolam | 2.73e-06 | 4 | 202 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 2.73e-06 | 4 | 202 | 3 | ctd:D011278 | |
| Drug | tetralol | 2.73e-06 | 4 | 202 | 3 | ctd:C019106 | |
| Drug | gliquidone | 2.73e-06 | 4 | 202 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.73e-06 | 4 | 202 | 3 | ctd:C018156 | |
| Drug | 1-acenaphthenol | 5.62e-06 | 14 | 202 | 4 | CID000022750 | |
| Drug | Hydroxysteroids | 6.79e-06 | 5 | 202 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 6.79e-06 | 5 | 202 | 3 | CID000257630 | |
| Drug | cresolphthalein | 6.79e-06 | 5 | 202 | 3 | ctd:C010092 | |
| Drug | Estazolam | 1.35e-05 | 6 | 202 | 3 | ctd:D004949 | |
| Drug | Glipizide | 1.35e-05 | 6 | 202 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.35e-05 | 6 | 202 | 3 | ctd:C023723 | |
| Drug | Medazepam | 1.35e-05 | 6 | 202 | 3 | ctd:D008472 | |
| Drug | duocarmycin | 2.35e-05 | 7 | 202 | 3 | CID000115369 | |
| Drug | zomepirac | 2.35e-05 | 7 | 202 | 3 | ctd:C020549 | |
| Drug | benzo(a)pyrene-7,8-dione | 2.61e-05 | 20 | 202 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 2.61e-05 | 20 | 202 | 4 | ctd:D002911 | |
| Drug | indanone | 3.02e-05 | 41 | 202 | 5 | CID000006735 | |
| Drug | Nitrazepam | 3.73e-05 | 8 | 202 | 3 | ctd:D009567 | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.27e-05 | 185 | 202 | 9 | 1673_DN | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 4.67e-05 | 23 | 202 | 4 | DB03461 | |
| Drug | 4-hydroxybenzoic acid | 5.56e-05 | 9 | 202 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 5.56e-05 | 9 | 202 | 3 | ctd:D004092 | |
| Drug | 9,10-phenanthrenequinone | 6.57e-05 | 25 | 202 | 4 | ctd:C005399 | |
| Drug | alpha-methylcinnamic acid | 7.83e-05 | 2 | 202 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 7.83e-05 | 2 | 202 | 2 | DB07768 | |
| Drug | baccharin | 7.83e-05 | 2 | 202 | 2 | ctd:C012764 | |
| Drug | 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE | 7.83e-05 | 2 | 202 | 2 | DB06831 | |
| Drug | octyl gallate | 7.89e-05 | 10 | 202 | 3 | ctd:C016627 | |
| Drug | bis(tri-n-butyltin)oxide | ORC6 ACLY RRM1 AKR1C2 CXCR4 PIK3CD PIK3CG BUB1B SYK GPD2 TMEM254 IGF2R ABCA5 FKBP7 EIF2A | 9.81e-05 | 538 | 202 | 15 | ctd:C005961 |
| Disease | Neoplasms, Hormone-Dependent | 3.02e-07 | 3 | 199 | 3 | C0027661 | |
| Disease | Hermaphroditism | 2.99e-06 | 5 | 199 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 2.99e-06 | 5 | 199 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.99e-06 | 5 | 199 | 3 | C0033804 | |
| Disease | Intersex Conditions | 2.99e-06 | 5 | 199 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.99e-06 | 5 | 199 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 1.04e-05 | 7 | 199 | 3 | C0036875 | |
| Disease | language measurement | 3.64e-05 | 134 | 199 | 7 | EFO_0007797 | |
| Disease | Obesity, Hyperphagia, and Developmental Delay | 4.53e-05 | 2 | 199 | 2 | C3151303 | |
| Disease | laryngeal squamous cell carcinoma, hypopharynx cancer | 4.53e-05 | 2 | 199 | 2 | EFO_0006352, EFO_0007321 | |
| Disease | Activated PI3K-delta syndrome | 4.53e-05 | 2 | 199 | 2 | cv:CN295305 | |
| Disease | alcohol and nicotine codependence | 8.22e-05 | 13 | 199 | 3 | EFO_0004776 | |
| Disease | ACTIVATED PI3K-DELTA SYNDROME | 1.35e-04 | 3 | 199 | 2 | C3714976 | |
| Disease | response to methotrexate | 1.59e-04 | 16 | 199 | 3 | GO_0031427 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.84e-04 | 42 | 199 | 4 | DOID:612 (is_implicated_in) | |
| Disease | Antihypertensive use measurement | 4.61e-04 | 265 | 199 | 8 | EFO_0009927 | |
| Disease | Endometrial Neoplasms | 6.41e-04 | 58 | 199 | 4 | C0014170 | |
| Disease | leiomyosarcoma (is_marker_for) | 6.67e-04 | 6 | 199 | 2 | DOID:1967 (is_marker_for) | |
| Disease | cortolone glucuronide (1) measurement | 6.67e-04 | 6 | 199 | 2 | EFO_0800552 | |
| Disease | Alcohol Related Birth Defect | 6.67e-04 | 6 | 199 | 2 | C3146244 | |
| Disease | Liver carcinoma | ACLY RRM1 AKR1C2 ADRA1A ANLN BUB1B COL15A1 TERT IGF2R ARID2 PITPNM3 | 7.02e-04 | 507 | 199 | 11 | C2239176 |
| Disease | cardiovascular disease | ARHGAP42 USP34 ZNF268 EFCAB13 ZNF831 PIK3R1 NAV1 GMDS AKR1B1 SLC7A1 | 1.15e-03 | 457 | 199 | 10 | EFO_0000319 |
| Disease | proteoglycan 3 measurement | 1.23e-03 | 8 | 199 | 2 | EFO_0802970 | |
| Disease | Endometrial Carcinoma | 1.44e-03 | 72 | 199 | 4 | C0476089 | |
| Disease | plexin-B2 measurement | 1.58e-03 | 9 | 199 | 2 | EFO_0021867 | |
| Disease | malignant epithelial tumor of ovary | 1.69e-03 | 35 | 199 | 3 | MONDO_0018364 | |
| Disease | Corneal astigmatism | 1.85e-03 | 77 | 199 | 4 | EFO_1002040 | |
| Disease | breast cancer, ovarian carcinoma | 1.98e-03 | 37 | 199 | 3 | EFO_0001075, MONDO_0007254 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 2.31e-03 | 39 | 199 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 2.39e-03 | 11 | 199 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.39e-03 | 11 | 199 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | campesterol measurement | 2.39e-03 | 11 | 199 | 2 | EFO_0020008 | |
| Disease | beverage consumption measurement | 2.43e-03 | 83 | 199 | 4 | EFO_0010088 | |
| Disease | Neoplastic Cell Transformation | 2.57e-03 | 139 | 199 | 5 | C0007621 | |
| Disease | Malignant neoplasm of breast | NRIP1 KLK10 STXBP4 EFCAB13 GPR180 ADRA1A CXCR4 OSBPL11 HERC2 KIT NLRP8 UBR4 SLC7A7 TERT LONRF3 CDC27 | 2.65e-03 | 1074 | 199 | 16 | C0006142 |
| Disease | Myeloproliferative disease | 2.86e-03 | 12 | 199 | 2 | C0027022 | |
| Disease | prostate carcinoma | TANC2 NRIP1 TMTC2 NOL10 ARMC2 BBX ANLN SYK GMDS AKR1B1 TERT ANKH ANKRD36 PHLPP2 | 3.03e-03 | 891 | 199 | 14 | EFO_0001663 |
| Disease | Prostatic Neoplasms | PIK3CD PIK3R1 COL15A1 TERT SLC7A1 IGF2R ARID2 AKR1C3 CDC27 ZMYM3 ZNF292 | 3.24e-03 | 616 | 199 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | PIK3CD PIK3R1 COL15A1 TERT SLC7A1 IGF2R ARID2 AKR1C3 CDC27 ZMYM3 ZNF292 | 3.24e-03 | 616 | 199 | 11 | C0376358 |
| Disease | Calcium channel blocker use measurement | 3.33e-03 | 213 | 199 | 6 | EFO_0009930 | |
| Disease | kynurenic acid measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0010506 | |
| Disease | male infertility (implicated_via_orthology) | 3.36e-03 | 13 | 199 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Hamman-Rich syndrome | 3.90e-03 | 14 | 199 | 2 | C0085786 | |
| Disease | glaucoma | 3.99e-03 | 154 | 199 | 5 | MONDO_0005041 | |
| Disease | prostate cancer (is_marker_for) | 4.21e-03 | 156 | 199 | 5 | DOID:10283 (is_marker_for) | |
| Disease | non-dense area measurement, mammographic density measurement | 4.49e-03 | 15 | 199 | 2 | EFO_0005941, EFO_0006504 | |
| Disease | Endometrioma | 4.81e-03 | 161 | 199 | 5 | C0269102 | |
| Disease | Endometriosis | 4.81e-03 | 161 | 199 | 5 | C0014175 | |
| Disease | neurotic disorder | 4.93e-03 | 101 | 199 | 4 | EFO_0004257 | |
| Disease | Weight Gain | 5.10e-03 | 102 | 199 | 4 | C0043094 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.10e-03 | 16 | 199 | 2 | C0334634 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 5.10e-03 | 16 | 199 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 5.76e-03 | 17 | 199 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Acute myeloid leukemia | 5.76e-03 | 17 | 199 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 5.76e-03 | 17 | 199 | 2 | 601626 | |
| Disease | Diuretic use measurement | 5.89e-03 | 169 | 199 | 5 | EFO_0009928 | |
| Disease | Premature atrial contractions | 6.13e-03 | 55 | 199 | 3 | HP_0006699 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 6.19e-03 | 171 | 199 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | Major Depressive Disorder | 6.28e-03 | 243 | 199 | 6 | C1269683 | |
| Disease | Adrenocortical carcinoma | 6.45e-03 | 18 | 199 | 2 | C0206686 | |
| Disease | pancreatic carcinoma | 6.65e-03 | 174 | 199 | 5 | EFO_0002618 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ISKYLKVSSHCNEGT | 541 | Q9BXU7 | |
| KYCATESLSSLVKQH | 716 | Q8WWZ7 | |
| CGTIYSQTLSIKKLS | 656 | O60566 | |
| KSSCTVAEIYLGNLA | 86 | P30411 | |
| NTDKLKNISSNYCLG | 216 | Q9N2K0 | |
| SERSCKGALYKTLVS | 611 | Q8WY36 | |
| LSCYCIIISKLSHSK | 216 | P61073 | |
| CKSKDIVLVAYSALG | 206 | P42330 | |
| YIVKKCIGRALSSSS | 456 | Q9H9E3 | |
| LALKAESNLSCGSYL | 346 | Q86SQ4 | |
| LCRKQSSKHALGYTL | 346 | P35348 | |
| YTCIAKNTKTLLSGS | 291 | Q2WEN9 | |
| GIYLTKSNAICHLKS | 176 | Q8NEN0 | |
| TLCLKTQGHSERYKA | 436 | Q5VV41 | |
| TAALILKNIGKYSEC | 1771 | Q68CP9 | |
| NKTDGCHAYLSKNSL | 411 | Q01518 | |
| TLAKTIACYSGQLAA | 1561 | A6QL64 | |
| AKTIACYSGQLAALT | 1001 | Q8N2N9 | |
| LLQLKSSATYGKSCQ | 216 | Q9H2F9 | |
| ELCLLTSGKLSYSLS | 611 | Q6DHV5 | |
| YADSNCLKTSGIKSQ | 146 | Q9UKW6 | |
| QVKYLFSDKTGTLTC | 421 | Q9NTI2 | |
| GACQKTLSDLKLDYL | 91 | P15121 | |
| KGTLANSASKDYTLH | 921 | Q149M9 | |
| AKTNTVSYKAGLICR | 201 | Q7Z401 | |
| LKSAQCGSSIIYHCK | 216 | P26715 | |
| CKALLDGLNKTTACY | 6 | Q6ZS82 | |
| KLKGISICYSALKSA | 826 | Q9H2T7 | |
| STQGKYKALSTCASH | 231 | Q8NGA2 | |
| ALSCIAESLKFYHKG | 586 | Q9NVH2 | |
| YSLNGVLQSESKCDK | 96 | Q9ULG1 | |
| CSKTGYSANIIFHTK | 581 | Q96SU4 | |
| YKCEVSSLAGALGKL | 331 | Q9H8H0 | |
| DLVAGSNCLKSSYVL | 181 | P43304 | |
| NSGLLKTLSVYEKHS | 346 | Q8NG48 | |
| KVQYAELKLCSSHSP | 856 | Q6DN12 | |
| KALKSSGLCESLTYG | 311 | Q8TC57 | |
| SVCGSKLSASALKYL | 576 | Q4G0Z9 | |
| YSHIQSKCGSKDNIK | 1001 | P27816 | |
| LSSVKCFHKLASAYG | 221 | Q08380 | |
| YSTVLTKSSLNKGCS | 301 | Q8NHV4 | |
| AGSLSLVLSTCKNIY | 701 | Q9NPP4 | |
| KLHYGDLTDSTCLVK | 81 | O60547 | |
| ALYKNLLHSKESSCS | 701 | P10721 | |
| LCSSYNRGLISKAKI | 256 | Q6W5P4 | |
| GYTNCGKTTLIKALT | 301 | O43824 | |
| QDYISSCGKKTLHEV | 71 | Q8N3F0 | |
| YGILTLCEAFSSQKK | 996 | Q86W28 | |
| SCKLRTLKLSYVSTA | 661 | P59045 | |
| GSLLKKYTALLCTHI | 1086 | O95714 | |
| YHSQESDGLVCLLKK | 91 | P43405 | |
| SLHAKYNTKTCATVV | 111 | P46020 | |
| SSLEGHIYLKIKCQV | 966 | Q9NQW6 | |
| LASKLSSGCDYALFK | 106 | A6NMX2 | |
| VVKCSIAKSQALYSA | 2866 | Q2LD37 | |
| KTKSCASLSARYLIQ | 681 | Q8NDZ0 | |
| NKLSYLACKLNSLVG | 3671 | Q5CZC0 | |
| TLKSCDLGTILSYQA | 141 | Q5T2Q4 | |
| LGYAVAVLHKTCSLS | 461 | P38570 | |
| AVLHKTCSLSYIAGA | 466 | P38570 | |
| DSVVLVGYKCLKSTA | 516 | Q9P2D6 | |
| VGYKCLKSTASNDLI | 521 | Q9P2D6 | |
| GVLSKCLAYSKAASD | 276 | Q8NDV2 | |
| GKNIDSKLHVTLYNC | 746 | O15031 | |
| LGCLATSNTEYLSKL | 741 | Q8NEN9 | |
| SYSKTAKQCLEEISG | 661 | Q8IVL0 | |
| CSASELKALGYKDVS | 536 | Q12996 | |
| TFSISKIHSLYGKCL | 431 | Q9H7Z3 | |
| KIHSLYGKCLSTLSA | 436 | Q9H7Z3 | |
| YGKCLSTLSAVKDGS | 441 | Q9H7Z3 | |
| KTSADVKALTYCGLQ | 641 | Q9UQ05 | |
| RCYGVASSHLKTLLK | 176 | P48552 | |
| KDKVYGVADSCTSLL | 941 | A8MYU2 | |
| KVLKILLYLCSHGSS | 71 | Q96N21 | |
| KLQQSSHGYSCSEKL | 81 | Q86V85 | |
| SHGYSCSEKLSKAQL | 86 | Q86V85 | |
| LNEVKIYSLSCGKSL | 6 | Q9BSC4 | |
| KKGLECSTLYRTQSS | 141 | P27986 | |
| ENLLSDKKTITYAGC | 81 | Q8NGP4 | |
| LGLLYSSTSCGVQKA | 21 | Q6PEW0 | |
| GILSKCLTYSKAVAD | 276 | Q96P69 | |
| KAYLGSAIQLVSCLS | 251 | Q9Y3T9 | |
| CYLECSALTQKGLKA | 171 | Q9H4E5 | |
| CTVSLIYAVHLKKSG | 186 | A8MWY0 | |
| NSKLCDLLLSKHGIY | 486 | P22557 | |
| SKRLLSTYICKVLGN | 541 | Q9UPT5 | |
| TSLHSLSNCKKLKYI | 831 | Q96JM4 | |
| CSHKNKSLQITYSLF | 56 | Q7Z6M3 | |
| LYSCVASNVAGTAKK | 2266 | Q96RW7 | |
| CLSGSILAKSKFYGN | 531 | Q9BZF1 | |
| SSIKSSICLLRGKIY | 126 | Q13042 | |
| CSKTSKKGDLLNAHY | 46 | Q9Y680 | |
| DLYSNCKSLKLTLTC | 211 | P54108 | |
| KGELLCSYSNNKSEL | 356 | Q9Y6W3 | |
| KCNTTSTLIIHTYGK | 176 | O95727 | |
| LSIVSSYNTCNKKKG | 1436 | Q8WZ74 | |
| LLAEKQYGFCKATLS | 221 | P02765 | |
| FCHLYKVTAVLKSQG | 451 | Q86TI2 | |
| AKTSKYLLDLCSAQH | 621 | Q68DX3 | |
| ALLSSGAVLYKACSV | 546 | Q14534 | |
| ISKYLLTCKTAHQLT | 851 | Q3T8J9 | |
| VLAGIACYAKTSSLT | 381 | Q5TEA3 | |
| ILLKHKYSFLVGCAS | 151 | Q9HCJ1 | |
| EISKVSKHQSYVGLC | 3021 | Q12955 | |
| ATDLSSGTINHKKYI | 26 | Q8IY85 | |
| LCKLPNQYSVHKTSS | 121 | Q8IY85 | |
| LSKECYSLTGKQSSA | 211 | Q9Y586 | |
| NYISKAGICHKVSTF | 246 | Q68D91 | |
| LVGLYCDKLSKTNFS | 21 | Q9UKA1 | |
| TKQYACLHDLTNKGI | 441 | Q9UKA1 | |
| LYDVKTGTCLKSFIQ | 111 | Q9BY44 | |
| ADKGTCKYVSLATLK | 126 | P60008 | |
| YSCDLTTLVKAHTTK | 266 | P15882 | |
| TYKLLKSVCGHLENT | 206 | Q96HH9 | |
| LSTGKILDQKAYSCA | 1356 | P39059 | |
| LSNKLTYEGKLECGS | 836 | P51530 | |
| TVYRLSKGCSLTKAQ | 2551 | Q92736 | |
| LAKGSECYQKSLSLN | 131 | P30260 | |
| NCIISGSYILTKAAL | 446 | O14772 | |
| KVSVNCAKTGYSASI | 586 | Q9BXB4 | |
| LGVVYTSHLQLKEKC | 481 | P0DJD0 | |
| FLSEKKTISYAGCLT | 86 | Q8NGR8 | |
| GASSRTSLCFKLYAK | 651 | P22897 | |
| GLLSYTDKLCSQKDF | 561 | Q8IVF1 | |
| ISELVNGALTCKYHK | 1636 | Q8NEY1 | |
| KSGLSYKSVISFVCR | 1601 | P11717 | |
| LSDVILQCYEGKSSK | 1841 | Q86VV8 | |
| LGLRDATSTKYKSVC | 426 | Q4G0N8 | |
| LCTGIKINSSAYRKA | 241 | Q9BRQ8 | |
| KTITSGLKNYLRCLA | 451 | A6NI28 | |
| CYLALSKFTSHLKNL | 1246 | Q8IVG5 | |
| AIQLYESLAKEGSCK | 166 | Q5TEA6 | |
| NYTCSIHLGNLVFKK | 231 | Q86YT9 | |
| SSSAKDEVKLLYLCA | 241 | Q96Q15 | |
| EKTKLLYTAGQSTHA | 1486 | Q96Q15 | |
| LETCSIALVGKYTKF | 296 | P17812 | |
| KLSSHLKTLSQGSYL | 641 | Q9HCD6 | |
| SHLDLLNKGQCVTKY | 381 | Q8IXF0 | |
| LSGLNKETYQSCLKS | 71 | Q9Y5N6 | |
| VKCSKSGDLYVLAAD | 321 | Q9NSE4 | |
| ILSSCEIKTGYNKTV | 161 | Q6ZWJ1 | |
| SLCLGSQLHGSTKYI | 651 | Q9NRH2 | |
| YKHGCKLAIISPTSQ | 546 | Q8N5C6 | |
| GKELLYKFICTTSAI | 11 | P53396 | |
| CKSKDIVLVAYSALG | 206 | Q04828 | |
| CKSKDIVLVAYSALG | 206 | P52895 | |
| FKESALTLACYKGHL | 371 | Q8IWZ3 | |
| KLSSTTKGICELENY | 111 | Q9BW66 | |
| AALLIQGSACVYSKK | 56 | Q6IBW4 | |
| IKSIGYSDLFCLSKD | 561 | P29973 | |
| GAILNESKYICTKIH | 321 | Q16620 | |
| LQIYCGKAPALSSKA | 431 | P48736 | |
| NLEVLTSKCLHGKNY | 1976 | Q96JI7 | |
| CKGCLVSLSYHLDTK | 36 | Q86UV6 | |
| NVCLAKVKGYRSLST | 861 | Q9NR97 | |
| LYECKQCGKALSSLT | 311 | Q8IYI8 | |
| ADHTTLLLNCYTKLK | 451 | Q9H270 | |
| IHTTVNSYKLEECGK | 191 | A8MTY0 | |
| HGQYSLLSKITFDKC | 356 | Q9UID6 | |
| QCGKTFSYKSSLVIH | 66 | Q9H963 | |
| KVSCNICGKLLSAAY | 286 | Q14119 | |
| CTTFGKLCLLSTKYL | 181 | Q14587 | |
| CEKAFSSKSYLLVHQ | 281 | Q14587 | |
| CGKSFSTGSYLIVHK | 401 | Q13360 | |
| STSCLYGKKLSNGSI | 1231 | Q6ZVD8 | |
| LLYRGTLKCNHSSKT | 1666 | Q13129 | |
| SGVYTCKLSTAKDEL | 1036 | Q15772 | |
| YSSLCSLSDQLAGKI | 96 | Q658P3 | |
| IYDTLKQCALISKSA | 231 | P23921 | |
| QKKSAGCHTLYLSSV | 576 | Q8IZW8 | |
| VRSLYVSCKSSGKFI | 51 | Q9HAI6 | |
| KYAVAVGSLCALSAS | 336 | P30825 | |
| LSTKQTEDYCLASNK | 241 | O43278 | |
| KAYSCALKSGKLVTA | 56 | O75717 | |
| HKSSVTSCLYNLGKL | 601 | Q8N394 | |
| HKGGYDELKQCLTTT | 126 | P0DPD5 | |
| GALCYAELGTTIKKS | 86 | Q9UM01 | |
| YILKGHKNTVCSLSS | 106 | Q9Y263 | |
| SLTTTQSKVFQCGKY | 136 | P0DKX0 | |
| KCKAGFNSYAELLTH | 756 | O60281 | |
| ISCFTQKLVEKLYSG | 1961 | Q6ZS81 | |
| KLHTCGKQFYISANL | 136 | Q13398 | |
| CSKDIQYLKDSLALG | 991 | O00329 | |
| GKNLTINCTSSKTLY | 36 | A0A0B4J273 | |
| CEYVSSLSKKGSLLV | 371 | Q15904 | |
| CFIKISAAYGSTKDI | 831 | Q9BZ71 | |
| KTKYAKSQSLGIICH | 571 | Q9UBW7 | |
| CEKLFSYKSSLIIHQ | 316 | Q9BY31 | |
| KQCGKSFSYSATLRI | 251 | Q9UC07 | |
| SECGKAFSSKSYLVI | 401 | P17031 | |
| VCGKAYISRSSLKNH | 481 | Q8NB50 | |
| CGKAYISLSSLINHK | 566 | Q8NB50 | |
| YSGLNQCLKTTLSKI | 66 | Q03924 | |
| CKGCLVSLSYHLDTK | 36 | Q86UV7 | |
| LAAAKKLCTLAQSYG | 1396 | O60346 | |
| HESCSGLYKLSLSGL | 1671 | Q70CQ2 | |
| KSTLTGNKVFNCISY | 291 | Q9GZL7 | |
| TCGIAFKTQSNLYKH | 176 | Q5JPB2 | |
| KSSGCSTYINRLIKV | 136 | Q5VZ18 | |
| LLELASTTKCSSVKY | 1071 | Q5T4S7 | |
| SLYAIVLCKHKGITS | 76 | Q8TBM7 | |
| SACTYGKSIDLVKFL | 311 | Q59H18 | |
| CEKSYFLKGSLVTHQ | 251 | Q6IV72 | |
| KHCGKVLSYLTSFQN | 341 | Q8N7K0 | |
| NKHYSCPTSEGIQKL | 721 | Q9UPU7 | |
| GKSLYCQAITTHSKS | 1996 | P15822 | |
| ISDTASLCYSILKAK | 1036 | O14746 | |
| ANGVSLLKDLYKCSE | 476 | Q9H3U1 | |
| LCCTTSYKVKQAGLT | 526 | Q14202 | |
| CGKAYTQRSSLTKHL | 671 | Q6ZNA1 | |
| SCRLKTHISNKYGKN | 196 | Q0VGE8 | |
| ASESLCGLKLEVNKY | 86 | P35625 | |
| LGKSLNCTVKTYSTS | 66 | Q9HAW9 | |
| LHTSKACNIISKYTA | 886 | Q5TIE3 | |
| CVGKSFHTYDVQKLS | 101 | Q8NI36 | |
| CVLISSKAVYFLKSG | 4276 | Q5THJ4 | |
| RVKYNKGLTCSSITI | 181 | O43240 | |
| DGLSQCLASRKYSKN | 506 | Q496Y0 |